A serum protein profile predictive of the resistance to neoadjuvant chemotherapy in advanced breast cancers

Molecular and Cellular Proteomics

Volumn 10, Issue 10, 2011, Pages

  Hyung, Seok Won ^a   Lee, Min Young ^b,c   Yu, Jong Han ^d   Shin, Byunghee ^c   Jung, Hee Jung ^a   Park, Jong Moon ^a   Han, Wonshik ^d   Lee, Kyung Min ^d   Moon, Hyeong Gon ^d   Zhang, Hui ^e   Aebersold, Ruedi ^f,g   Hwang, Daehee ^b   Lee, Sang Won ^a   Yu, Myeong Hee ^c   Noh, Dong Young ^d  

^a Korea University   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

^d Seoul National University   (South Korea)

^e Cancer Research Building II   (United States)

^f INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^g UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; BIOLOGICAL MARKER; CERULOPLASMIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C9; DOCETAXEL; DOXORUBICIN; FETUIN A; OROSOMUCOID; PROTEOME; ANTINEOPLASTIC AGENT; GLYCOPROTEIN; PHARMACOLOGICAL BIOMARKER; PLASMA PROTEIN;

ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; ADJUVANT THERAPY; ADULT; BLOOD; BREAST TUMOR; CANCER STAGING; DRUG RESISTANCE; GENETICS; MIDDLE AGED; PATHOLOGY; PROTEOMICS; STAINING;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOMARKERS, PHARMACOLOGICAL; BLOOD PROTEINS; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; GLYCOPROTEINS; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROTEOMICS; STAINING AND LABELING;

EID: 80054014390     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.011023-1     Document Type: Article

References (51)

1. WHO (2009) Fact sheet No297
2. Rastogi, P., Anderson, S. J., Bear, H. D., Geyer, C. E., Kahlenberg, M. S., Robidoux, A., Margolese, R. G., Hoehn, J. L., Vogel, V. G., Dakhil, S. R., Tamkus, D., King, K. M., Pajon, E. R., Wright, M. J., Robert, J., Paik, S., Mamounas, E. P., and Wolmark, N. (2008) Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin. Oncol. 26, 778-785 (Pubitemid 351264391)
3. Makris, A., Powles, T. J., Ashley, S. E., Chang, J., Hickish, T., Tidy, V. A., Nash, A. G., and Ford, H. T. (1998) A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann. Oncol. 9, 1179-1184 (Pubitemid 28552806)
4. Smith, I. C., Heys, S. D., Hutcheon, A. W., Miller, I. D., Payne, S., Gilbert, F. J., Ah-See, A. K., Eremin, O., Walker, L. G., Sarkar, T. K., Eggleton, S. P., and Ogston, K. N. (2002) Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J. Clin. Oncol. 20, 1456-1466 (Pubitemid 34260523)
5. Ravdin, P. M. (1995) Anthracycline resistance in breast cancer: clinical applications of current knowledge. Eur. J. Cancer 31A Suppl 7, S11-14
6. Nielsen, D., Maare, C., and Skovsgaard, T. (1996) Cellular resistance to anthracyclines. Gen. Pharmacol. 27, 251-255 (Pubitemid 26129184)
7. Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S. X., Lonning, P. E., Børresen- Dale, A. L., Brown, P. O., and Botstein, D. (2000) Molecular portraits of human breast tumours. Nature 406, 747-752
8. Frasor, J., Chang, E. C., Komm, B., Lin, C. Y., Vega, V. B., Liu, E. T., Miller, L. D., Smeds, J., Bergh, J., and Katzenellenbogen, B. S. (2006) Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res. 66, 7334-7340 (Pubitemid 44197716)
9. van de Vijver, M. J., He, Y. D., van't Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., Parrish, M., Atsma, D., Witteveen, A., Glas, A., Delahaye, L., van der Velde, T., Bartelink, H., Rodenhuis, S., Rutgers, E. T., Friend, S. H., and Bernards, R. (2002) A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999-2009 (Pubitemid 35461656)
10. Troester, M. A., Hoadley, K. A., Parker, J. S., and Perou, C. M. (2004) Prediction of toxicant-specific gene expression signatures after chemotherapeutic treatment of breast cell lines. Environ. Health Perspect. 112, 1607-1613 (Pubitemid 41309821)
11. Troester, M. A., Hoadley, K. A., Sørlie, T., Herbert, B. S., Børresen-Dale, A. L., Lønning, P. E., Shay, J. W., Kaufmann, W. K., and Perou, C. M. (2004) Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res. 64, 4218-4226 (Pubitemid 38802426)
12. Barry, W. T., Kernagis, D. N., Dressman, H. K., Griffis, R. J., Hunter, J. D., Olson, J. A., Marks, J. R., Ginsburg, G. S., Marcom, P. K., Nevins, J. R., Geradts, J., and Datto, M. B. Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome. J. Clin. Oncol. 28, 2198-2206
13. Gehrmann, M. L., Hathout, Y., and Fenselau, C. (2004) Evaluation of metabolic labeling for comparative proteomics in breast cancer cells. J. Proteome Res. 3, 1063-1068 (Pubitemid 39425664)
14. Sarvaiya, H. A., Yoon, J. H., and Lazar, I. M. (2006) Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation. Rapid Commun. Mass Spectrom. 20, 3039-3055 (Pubitemid 44569783)
15. Hudelist, G., Singer, C. F., Pischinger, K. I., Kaserer, K., Manavi, M., Kubista, E., and Czerwenka, K. F. (2006) Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium. Proteomics 6, 1989-2002
16. Zang, L., Palmer Toy, D., Hancock, W. S., Sgroi, D. C., and Karger, B. L. (2004) Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling. J. Proteome Res. 3, 604-612 (Pubitemid 39207366)
17. Li, J., Orlandi, R., White, C. N., Rosenzweig, J., Zhao, J., Seregni, E., Morelli, D., Yu, Y., Meng, X. Y., Zhang, Z., Davidson, N. E., Fung, E. T., and Chan, D. W. (2005) Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry. Clin. Chem. 51, 2229-2235 (Pubitemid 41692564)
18. Schaub, N. P., Jones, K. J., Nyalwidhe, J. O., Cazares, L. H., Karbassi, I. D., Semmes, O. J., Feliberti, E. C., Perry, R. R., and Drake, R. R. (2009) Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients. J. Am. Coll. Surg. 208, 970-978, discussion 978-980
19. Iwao-Koizumi, K., Matoba, R., Ueno, N., Kim, S. J., Ando, A., Miyoshi, Y., Maeda, E., Noguchi, S., and Kato, K. (2005) Prediction of docetaxel response in human breast cancer by gene expression profiling. J. Clin. Oncol. 23, 422-431 (Pubitemid 46224217)
20. Végran, F., Boidot, R., Coudert, B., Fumoleau, P., Arnould, L., Garnier, J., Causeret, S., Fraise, J., Dembélé, D., and Lizard-Nacol, S. (2009) Gene expression profile and response to trastuzumab-docetaxel-based treatment in breast carcinoma. Br. J. Cancer 101, 1357-1364
21. Zembutsu, H., Suzuki, Y., Sasaki, A., Tsunoda, T., Okazaki, M., Yoshimoto, M., Hasegawa, T., Hirata, K., and Nakamura, Y. (2009) Predicting response to docetaxel neoadjuvant chemotherapy for advanced breast cancers through genome-wide gene expression profiling. Int. J. Oncol. 34, 361-370
22. Gottesman, M. M., Pastan, I., and Ambudkar, S. V. (1996) P-glycoprotein and multidrug resistance. Curr. Opin. Genet. Dev. 6, 610-617 (Pubitemid 26372158)
23. Renes, J., de Vries, E. G., Jansen, P. L., and Müller, M. (2000) The (patho-) physiological functions of the MRP family. Drug Resist. Updat. 3, 289-302
24. Leonessa, F., and Clarke, R. (2003) ATP binding cassette transporters and drug resistance in breast cancer. Endocr. Relat. Cancer 10, 43-73 (Pubitemid 36457239)
25. Lin, J. C., Chang, S. Y., Hsieh, D. S., Lee, C. F., and Yu, D. S. (2005) The association of Id-1, MIF and GSTpi with acquired drug resistance in hormone independent prostate cancer cells. Oncol. Rep. 13, 983-988
26. Burg, D., Riepsaame, J., Pont, C., Mulder, G., and van de Water, B. (2006) Peptide-bond modified glutathione conjugate analogs modulate GSTpi function in GSH-conjugation, drug sensitivity and JNK signaling. Biochem. Pharmacol. 71, 268-277 (Pubitemid 41817287)
27. Jansen, M. P., Foekens, J. A., van Staveren, I. L., Dirkzwager-Kiel, M. M., Ritstier, K., Look, M. P., Meijer-van Gelder, M. E., Sieuwerts, A. M., Portengen, H., Dorssers, L. C., Klijn, J. G., and Berns, E. M. (2005) Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling. J. Clin. Oncol. 23, 732-740 (Pubitemid 46224172)
28. Umar, A., Kang, H., Timmermans, A. M., Look, M. P., Meijer-van Gelder, M. E., den Bakker, M. A., Jaitly, N., Martens, J. W., Luider, T. M., Foekens, J. A., and Pasa-Tolić, L. (2009) Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer. Mol. Cell. Proteomics 8, 1278-1294
29. Zhang, H., Li, X. J., Martin, D. B., and Aebersold, R. (2003) Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 21, 660-666 (Pubitemid 36638093)
30. Zhou, Y., Aebersold, R., and Zhang, H. (2007) Isolation of N-linked glycopeptides from plasma. Anal. Chem. 79, 5826-5837 (Pubitemid 47229834)
31. Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., and Gwyther, S. G. (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl. Cancer Inst. 92, 205-216
32. Min, H. K., Hyung, S. W., Shin, J. W., Nam, H. S., Ahn, S. H., Jung, H. J., and Lee, S. W. (2007) Ultrahigh-pressure dual online solid phase extraction/ capillary reverse-phase liquid chromatography/tandem mass spectrometry (DO-SPE/cRPLC/MS/MS): a versatile separation platform for high-throughput and highly sensitive proteomic analyses. Electrophoresis 28, 1012-1021 (Pubitemid 46554605)
33. Shin, B., Jung, H. J., Hyung, S. W., Kim, H., Lee, D., Lee, C., Yu, M. H., and Lee, S. W. (2008) Postexperiment monoisotopic mass filtering and refinement (PE-MMR) of tandem mass spectrometric data increases accuracy of peptide identification in LC/MS/MS. Mol. Cell. Proteomics 7, 1124-1134 (Pubitemid 351943959)
34. Elias, J. E., and Gygi, S. P. (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207-214 (Pubitemid 46358868)
35. Zimmer, J. S., Monroe, M. E., Qian, W. J., and Smith, R. D. (2006) Advances in proteomics data analysis and display using an accurate mass and time tag approach. Mass Spectrom. Rev. 25, 450-482
36. Fay, M. P., and Proschan, M. A. (2010) Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules. Statistics Surveys 4, 1-39
37. Storey, J. D., and Tibshirani, R. (2003) Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. U.S.A. 100, 9440-9445 (Pubitemid 37033947)
38. Conover, W. J. (1980) Practical Nonparametric statistics, 2nd Edition. John Wiley & Sons, New York
39. Motulsky, H. (2007) Statistics Guide. GraphPad Software Inc.
40. Geladi, P., and Kowalski, B. R. (1986) Partial least-squares regression: a tutorial. Analyt. Chim. Acta 185, 1-17
41. Chong, I. G., and Jun, C. H. (2005) Performance of some variable selection methods when multicollinearity is present. Chemometr. Intell. Lab. 78, 103-112
42. Umetrics, A. B. (2005) User's guide to SIMCA-P, SIMCA-P+ version 11.0
43. Chang, J. W., Kang, U. B., Kim, D. H., Yi, J. K., Lee, J. W., Noh, D. Y., Lee, C., and Yu, M. H. (2008) Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer. Proteomics Clin. Appl. 2, 23-32 (Pubitemid 351210913)
44. Bolstad, B. M., Irizarry, R. A., Astrand, M., and Speed, T. P. (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193 (Pubitemid 36181903)
45. Mueller, L. N., Rinner, O., Schmidt, A., Letarte, S., Bodenmiller, B., Brusniak, M. Y., Vitek, O., Aebersold, R., and Müller, M. (2007) SuperHirn - a novel tool for high resolution LC-MS-based peptide/protein profiling. Proteomics 7, 3470-3480 (Pubitemid 47597670)
46. Chang, J. C., Wooten, E. C., Tsimelzon, A., Hilsenbeck, S. G., Gutierrez, M. C., Tham, Y. L., Kalidas, M., Elledge, R., Mohsin, S., Osborne, C. K., Chamness, G. C., Allred, D. C., Lewis, M. T., Wong, H., and O'Connell, P. (2005) Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients. J. Clin. Oncol. 23, 1169-1177 (Pubitemid 46202273)
47. Graf, W., Påhlman, L., Bergström, R., and Glimelius, B. (1994) The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer. Br. J. Cancer 70, 559-563 (Pubitemid 24268565)
48. Tiersten, A. D., Moon, J., Smith, H. O., Wilczynski, S. P., Robinson, W. R., 3rd, Markman, M., and Alberts, D. S. (2009) Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group Study. Oncology 77, 395-399
49. Marsh, S., and Liu, G. (2009) Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy. Adv. Drug Deliv. Rev. 61, 381-387
50. Schapira, D. V., and Schapira, M. (1983) Use of ceruloplasmin levels to monitor response to therapy and predict recurrence of breast cancer. Breast Cancer Res. Treat. 3, 221-224 (Pubitemid 13040300)
51. Kusama, M., Miyauchi, K., Aoyama, H., Sano, M., Kimura, M., Mitsuyama, S., Komaki, K., and Doihara, H. (2004) Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipids in postmenopausal patients with breast cancer. Breast Cancer Res. Treat. 88, 1-8 (Pubitemid 39524439)